Day: November 12, 2021

Press contact:Victoire GruxTel.:+33 6 04 52 16 55E-mail: victoire.grux@capgemini.com Stockholm (Sweden) and Paris (France), November 12, 2021 – In support of its long-term commitment to innovation and technology, Capgemini announces today a three-year global partnership with Nobel Prize Outreach to support innovation and science, in line with Alfred Nobel’s vision and legacy to honor achievements “for the greatest benefit to humankind”Laura Sprechmann, CEO of Nobel Prize Outreach, Aiman Ezzat, CEO of Capgemini and Vidar Helgesen, Executive Director, Nobel Foundation during the signing of the partnership on November 12, 2021 in Stockholm. © Dan Lepp Nobel Prize Outreach Capgemini joins the select group of Nobel International Partners, five companies that are all fueled by the same commitment and passion to share knowledge and excellence...

Considering that during the shares buy-back process of INVL Technology (hereinafter – “the Company”), the Company acquired 107,686 shares (0.88 % of own shares) for EUR 295,059.64 from the Company’s shareholders for which they were paid on 12 November 2021, the Company announces the data on shares issued by the Company as of 12 November 2021:Type of shares Number of shares and total voting rights granted by the issued shares, units Number of votes for the quorum of the General Shareholders Meeting, units* Nominal value, EUR Total nominal Value and authorised capital, EUR Portion of the authorised capital, %Ordinary registered shares 12,175,321 12,067,635 0.29 3,530,843.09 100*According to the Law on Securities of the Republic of Lithuania, the shares owned by the Company are not considered to be deducted from the total number...

BERKELEY, Calif. and VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, today announces the following updates: Pursuant to the securities buyback program announced Sept. 9, 2021, BriaCell has repurchased 202,425 common shares (the “Common Shares”) and 70,246 publicly traded BCTXW warrants (the “Listed Warrants”). As announced, BriaCell may purchase through the facilities of the TSX Venture Exchange (“TSXV”) or the Nasdaq Capital Market (“Nasdaq”) or alternative exchanges (i) up to 1,341,515 Common Shares and (ii) up to 411,962 publicly traded BCTXW Listed Warrants in total, representing...

– Live moderated video webcast discussion among management and Pediatric Dermatology Thought Leader on Wednesday, November 17th at 1:00 PM ET – DURHAM, N.C., Nov. 12, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, joined by a pediatric dermatology thought leader, will participate in the Virtual Investor Roundtable Event on Wednesday, November 17, 2021 at 1:00 PM ET. As part of the virtual event, the Company will provide a brief presentation, followed by a moderated roundtable discussion and an interactive Q&A session where all investors and interested parties will have the opportunity to submit questions live during the event. Interested parties may also pre-submit questions in advance of the live event,...

Seattle, Nov. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — 3DX Industries Inc. (DDDX) (the “Company” or “3DX”), a state of the art additive manufacturer specializing in 3D Metal Printing, announced it will start accepting Bitcoin and Ethereum as payment for manufacturing services via Coinbase. 3DX Industries, Inc. is once again pioneering the use of technology to transform manufacturing markets, plugging into the open monetary network and accepting Bitcoin and Ethereum via a fully integrated digital process, according to Nicholas Coriano, VP & Board Member at 3DX Industries, Inc. “We are firmly focused on making USA based manufacturing accessible and possible for millions of people across the world,” said Mr. Coriano.  “As we expand our capabilities via our acquisition strategy, Bitcoin and Ethereum can solve some...

Abivertinib is a novel third-generation epidermal growth factor receptor (EGFR) inhibitor that irreversibly targets mutant forms of EGFR and Bruton’s tyrosine kinase (BTK) in advanced NSCLC patients resistant to first-line EGFR kinase inhibitor therapies.In this pivotal study conducted in China, 227 heavily pretreated NSCLC patients were enrolled and among 209 response evaluable patients, confirmed overall response rate (ORR) was 52.2%. Disease control rate (DCR) was 88.0%. The median duration of response (DoR) and progression-free survival (PFS) was 8.5 months and 7.5 months, respectively. The median overall survival (OS) was 24.9 months. Based on these significant treatment benefits that Abivertinib achieved in a heavily pretreated population, Sorrento is conducting an independent review process with more mature long-term data and...

After an action-packed first two rounds, drivers will take on the long challenge of Nordschleife on Saturday at 7:30 a.m. ETLe Mans Virtual SeriesDrivers take on NordschleifeMIAMI, Nov. 12, 2021 (GLOBE NEWSWIRE) — The 8 Hours of Nürburgring takes place this weekend, which will be the longest race of the Le Mans Virtual Series to date. Le Mans Virtual Series is a joint venture between Motorsport Games and the Automobile Club de l’Ouest. The third of five rounds for the 2021-22 season, which will come to an end with the 24 Hours of Le Mans Virtual in January of 2022, will be the biggest challenge yet for the 114 professional and sim racing drivers participating across the 38 prototype and GTE entries (entry list HERE) on the famously difficult 21 km/13 mile Nordschleife circuit in Germany. With over 100 corners,...

Picture 1In Q4 2021, California-based wholesalers in Los Angeles, San Diego, and San Francisco have placed pallet orders of TAAT™, which they will begin distributing in their respective markets as the Company seeks to expand its existing presence across the stateLAS VEGAS and VANCOUVER, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) — TAAT™ GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT™”) is pleased to announce that it has shipped multiple pallets of TAAT™ to fill purchase orders from three California-based distributors, who each primarily serve retailers in the areas of Los Angeles (population 3.9 million), San Diego (population 1.4 million), and San Francisco (population 875,000). After successfully launching TAAT™ at retail in Ohio in Q4 2020, the Company began...

Patrick BlairPatrick BlairDENVER, Nov. 12, 2021 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors, announced today that its board of directors has appointed Patrick Blair as President effective Dec.1, 2021. Blair’s initial responsibilities will be to run InnovAge’s operations and execute on its near-term growth plans, including expansion into three new sites in fiscal year 2023. Blair brings a wealth of experience to this role, having held senior positions at leading health plans and the nation’s largest non-profit home health care provider. InnovAge Board Chair and Apax Partner Andrew Cavanna said, “We are proud to have such a high calibre and experienced executive joining InnovAge...

SHELTON, Conn., Nov. 12, 2021 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) announced that it has established a pre-arranged trading plan, as part of the Company’s existing stock repurchase programs, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The Rule 10b5-1 trading plan will permit common stock to be repurchased over a twelve-month period, at times that the Company might otherwise be precluded from doing so under insider trading laws or self-imposed trading restrictions. The Rule 10b5-1 trading plan will be administered by an independent broker and will be subject to preset price, volume and timing restrictions set forth in the plan. Repurchases of shares under the Rule 10b5-1 Plan will also be intended to comply with the requirements of Rule 10b-18 under the Exchange Act....